Sanofi to divest its stake in the Yves Rocher Group
4 July 2012 | By Sanofi
"We are pleased to have been able to support the development of the Yves Rocher Group for about 40 years...”
List view / Grid view
4 July 2012 | By Sanofi
"We are pleased to have been able to support the development of the Yves Rocher Group for about 40 years...”
19 June 2012 | By Sanofi
Sanofi and the Joslin Diabetes Center announced a new collaboration...
13 June 2012 | By Sanofi
Sanofi granted the award for “Leading Pan-European Quoted Company for Investor Relations”...
12 June 2012 | By Sanofi
Genzyme is developing LEMTRADA in MS in collaboration with Bayer HealthCare...
11 June 2012 | By Sanofi
New results of a large-scale epidemiological program announced...
11 June 2012 | By Sanofi
Sanofi announced that the marketing authorization application for Lyxumia®...
28 May 2012 | By Sanofi
The group pledges continuous commitment to diabetes management in China...
16 May 2012 | By Sanofi
Progress on Jevtana®, Zaltrap™ and JAK2 inhibitor featured...
3 May 2012 | By Sanofi
FDA and the EMA approve 2nd operation for filling and finishing product...
30 April 2012 | By Citigate Dewe Rogerson
Algeta ASA announces that its research collaboration with Sanofi has been extended...
27 April 2012 | By Sanofi
Approval of IMOVAX® POLIO by Japanese health authorities...
20 April 2012 | By Sanofi
Full CARE-MS II results for Alemtuzumab to be unveiled...
19 April 2012 | By Sanofi
Fox Foundation to sponsor a clinical trial to study Sanofi compound...
5 April 2012 | By Sanofi
The FDA has granted Priority Review of the BLA for the investigational agent Zaltrap®...
26 March 2012 | By Sanofi
Data from two Phase 2 trials announced...